ONESOURCE
Onesource Specialty Pharma Limited
Pharmaceuticals
Share price
₹1,609
Market cap
₹18,510 Cr
1Y return
▼ 4%
A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.
Investors holding Onesource Specialty Pharma Limited
2.89%
1.79%
1.76%
1.62%
1.58%
1.38%
1.24%
1.05%
Recent moves 16
Moves16
2newest moves
Members onlyIncluding 1 new position
Unlock all 2 movesAxis Mutual FundIncreased
Axis Mutual Fund raised its stake in Onesource Specialty Pharma Limited from 1.33% to 1.38%, purchasing 59,382 shares.
Read more
SBI Life InsuranceIncreased
SBI Life Insurance increased its stake in Onesource Specialty Pharma Limited from 2.06% to 2.89%, buying 9,41,990 shares.
Read more
Amansa HoldingsDecreased
Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 1.86% to 1.58%. The fund sold 3,14,836 shares, reducing its holding to 18,17,076 shares.
Read more
Motilal Oswal Mutual FundDecreased
Motilal Oswal Mutual Fund trimmed its stake in Onesource Specialty Pharma from 7.06% to 7.02%, selling 45,555 shares.
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund reduced its stake in Onesource Specialty Pharma Limited from 1.22% to 1.13%, selling 1,07,749 shares.
Read more
Amansa HoldingsDecreased
Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 3.47% to 1.86%, selling 1,841,289 shares.
Read more
FidelityNew position
Fidelity bought 20,20,423 shares of Onesource Specialty Pharma Limited, a 1.76% stake.
Read more
SBI Life InsuranceDecreased
SBI Life Insurance decreased its stake in Onesource Specialty Pharma Limited from 2.53% to 2.06% by selling 535,750 shares.
Read more
Axis Mutual FundDecreased
Axis Mutual Fund decreased its stake in Onesource Specialty Pharma Limited from 1.47% to 1.33% by selling 155,669 shares.
Read more
Authum Investment & InfrastructureDecreased
Authum Investment & Infrastructure reduced its stake in Onesource Specialty Pharma Limited from 5.16% to 4.96% by decreasing its shareholding from 5,909,646 to 5,681,844 shares. This involved selling 227,802 shares, crossing the 5% disclosure threshold.
Read more
Track the whales in Onesource Specialty Pharma Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1